These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 3575945)
1. [High density lipoprotein cholesterol in obese non-insulin-dependent diabetic patients]. Arteaga A; Velasco N; Maiz A; Villanueva C; Acosta AM Rev Med Chil; 1986 Jun; 114(6):509-15. PubMed ID: 3575945 [No Abstract] [Full Text] [Related]
2. Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia. Ismail IS; Nazaimoon W; Mohamad W; Letchuman R; Singaraveloo M; Hew FL; Shuguna C; Khalid BA Diabet Med; 2001 Jun; 18(6):501-8. PubMed ID: 11472471 [TBL] [Abstract][Full Text] [Related]
3. Positive health beliefs are associated with improvement of glycated hemoglobin and lipid profiles in Mexican patients with type 2 diabetes mellitus: a cross-sectional study. Muñoz-Torres AV; Medina-Bravo P; Valerio-Pérez BE; Mendoza-Salmeron G; Escobedo-de la Peña J; Velázquez-López L BMC Public Health; 2020 May; 20(1):761. PubMed ID: 32448139 [TBL] [Abstract][Full Text] [Related]
4. Sex differences in plasma cholesterol and apolipoprotein B levels in non-obese type 2 diabetic subjects. Ikeda T; Terasawa H; Ishimura M; Ochi H; Ohtani D; Fujiyama K; Hoshino T; Tanaka Y; Mashiba H Diabete Metab; 1992; 18(6):465-7. PubMed ID: 1297605 [No Abstract] [Full Text] [Related]
5. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians. Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM. Cusi K; Cunningham GR; Comstock JP Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511 [TBL] [Abstract][Full Text] [Related]
7. Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients? Alagözlü H; Gültekin F; Candan F Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):204-8. PubMed ID: 11079258 [TBL] [Abstract][Full Text] [Related]
8. A telephone-delivered intervention for patients with NIDDM. Effect on coronary risk factors. Kirkman MS; Weinberger M; Landsman PB; Samsa GP; Shortliffe EA; Simel DL; Feussner JR Diabetes Care; 1994 Aug; 17(8):840-6. PubMed ID: 7956628 [TBL] [Abstract][Full Text] [Related]
9. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects. Ozata M; Gungor D; Turan M; Ozisik G; Bingol N; Ozgurtas T; Ozdemir IC J Clin Endocrinol Metab; 2001 Aug; 86(8):3659-64. PubMed ID: 11502793 [TBL] [Abstract][Full Text] [Related]
10. Serum lipoprotein(a) is not increased in NIDDM patients with microalbuminuria. Girelli A; Cimino A; Rocca L; Salvi A; Spandrio S; Valentini U; Guistina A Diabetes Care; 1994 May; 17(5):456-7. PubMed ID: 8062619 [No Abstract] [Full Text] [Related]
11. Prevalence of obesity in Korean non-insulin-dependent diabetic patients. Lee TH Diabetes Res Clin Pract; 1996 Apr; 32(1-2):71-80. PubMed ID: 8803484 [TBL] [Abstract][Full Text] [Related]
12. [Changes in carbohydrate and lipid metabolism in obesity]. Actis Dato SM; Pittana J; Costa Gil JE; Nieto RE Medicina (B Aires); 1986; 46(6):677-85. PubMed ID: 3306255 [No Abstract] [Full Text] [Related]
13. Plasma cholesteryl ester transfer and hepatic lipase activity are related to high-density lipoprotein cholesterol in association with insulin resistance in type 2 diabetic and non-diabetic subjects. Riemens SC; van Tol A; Scheek LM; Dullaart RP Scand J Clin Lab Invest; 2001 Feb; 61(1):1-9. PubMed ID: 11300605 [TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy and tolerability of pravastatin in hypercholesterolemia in patients with non-insulin-dependent diabetes mellitus. Hyogo Pravastatin Study Group. Kazumi T; Yoshino G; Ishida Y; Iwatani I; Morita S; Tateiwa M; Kasuga M Diabetes Res Clin Pract; 1995 Jan; 27(1):61-8. PubMed ID: 7781495 [TBL] [Abstract][Full Text] [Related]
15. Modification of therapy from insulin to chlorpropamide decreases HDL cholesterol in patients with non-insulin-dependent diabetes mellitus. Schmitt JK; Harriman K; Poole JR Diabetes Care; 1987; 10(6):692-6. PubMed ID: 3322724 [TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control. Bavirti S; Ghanaat F; Tayek JA Endocr Pract; 2003; 9(6):487-93. PubMed ID: 14715475 [TBL] [Abstract][Full Text] [Related]
17. Lipid and lipoprotein aberrations in Indian patients with non-insulin-dependent diabetes in the young. Jialal I; Deppe W; Joubert SM S Afr Med J; 1985 Jun; 67(25):1001-4. PubMed ID: 4012462 [TBL] [Abstract][Full Text] [Related]
18. Some determinants of postprandial lipaemia in Nigerian diabetic and non-diabetic subjects. Akanji AO; Nzegwu AA; Agbedana EO Br J Nutr; 1992 Jul; 68(1):153-62. PubMed ID: 1390600 [TBL] [Abstract][Full Text] [Related]
19. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Kesavulu MM; Giri R; Kameswara Rao B; Apparao C Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018 [TBL] [Abstract][Full Text] [Related]
20. Sex differences in the effect of HbA1c-defined diabetes on a wide range of cardiovascular disease risk factors. Du T; Yuan G; Zhou X; Sun X Ann Med; 2016; 48(1-2):34-41. PubMed ID: 26758477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]